Preferences of Patients With HR1 & HER2- Breast Cancer Regarding Hormonal and Targeted Therapies in the First Line of Their Metastatic Stage: A Discrete Choice Experiment

Preferences of Patients With HR1 & HER2- Breast Cancer Regarding Hormonal and Targeted Therapies in the First Line of Their Metastatic Stage: A Discrete Choice Experiment
A. Nazari, B. González López-Valcárcel, S. Najafi. Value in Health Regional Issues, 2021, 25, pp. 7 - 14.   Fulltext   Abstract
Journal article